IT202200010592A1 - “Composizione nutraceutica o farmaceutica per l’infertilità maschile” - Google Patents
“Composizione nutraceutica o farmaceutica per l’infertilità maschile” Download PDFInfo
- Publication number
- IT202200010592A1 IT202200010592A1 IT102022000010592A IT202200010592A IT202200010592A1 IT 202200010592 A1 IT202200010592 A1 IT 202200010592A1 IT 102022000010592 A IT102022000010592 A IT 102022000010592A IT 202200010592 A IT202200010592 A IT 202200010592A IT 202200010592 A1 IT202200010592 A1 IT 202200010592A1
- Authority
- IT
- Italy
- Prior art keywords
- nutraceutical
- pharmaceutical composition
- male infertility
- infertility
- male
- Prior art date
Links
- 208000007466 Male Infertility Diseases 0.000 title 1
- 239000002417 nutraceutical Substances 0.000 title 1
- 235000021436 nutraceutical agent Nutrition 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Reproductive Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Nutrition Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102022000010592A IT202200010592A1 (it) | 2022-05-23 | 2022-05-23 | “Composizione nutraceutica o farmaceutica per l’infertilità maschile” |
PCT/IB2023/055270 WO2023228062A1 (en) | 2022-05-23 | 2023-05-23 | Nutraceutical or pharmaceutical composition for male infertility |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102022000010592A IT202200010592A1 (it) | 2022-05-23 | 2022-05-23 | “Composizione nutraceutica o farmaceutica per l’infertilità maschile” |
Publications (1)
Publication Number | Publication Date |
---|---|
IT202200010592A1 true IT202200010592A1 (it) | 2023-11-23 |
Family
ID=83081723
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT102022000010592A IT202200010592A1 (it) | 2022-05-23 | 2022-05-23 | “Composizione nutraceutica o farmaceutica per l’infertilità maschile” |
Country Status (2)
Country | Link |
---|---|
IT (1) | IT202200010592A1 (it) |
WO (1) | WO2023228062A1 (it) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003057201A2 (en) * | 2002-01-11 | 2003-07-17 | Matthias Rath | A nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer |
WO2012164535A1 (en) * | 2011-06-03 | 2012-12-06 | Lo.Li.Pharma S.R.L. | Antioxidant composition for the reduction of the causes of reduced male reproductive capacity |
US20130295068A1 (en) * | 2006-02-03 | 2013-11-07 | Fapa Vital Anstalt | Combination preparation for improving sperm quality |
WO2017125918A1 (en) * | 2016-01-18 | 2017-07-27 | Amorphical Ltd. | Stabilized amorphous calcium carbonate for treatment of neurological, muscular and infertility diseases or conditions |
-
2022
- 2022-05-23 IT IT102022000010592A patent/IT202200010592A1/it unknown
-
2023
- 2023-05-23 WO PCT/IB2023/055270 patent/WO2023228062A1/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003057201A2 (en) * | 2002-01-11 | 2003-07-17 | Matthias Rath | A nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer |
US20130295068A1 (en) * | 2006-02-03 | 2013-11-07 | Fapa Vital Anstalt | Combination preparation for improving sperm quality |
WO2012164535A1 (en) * | 2011-06-03 | 2012-12-06 | Lo.Li.Pharma S.R.L. | Antioxidant composition for the reduction of the causes of reduced male reproductive capacity |
WO2017125918A1 (en) * | 2016-01-18 | 2017-07-27 | Amorphical Ltd. | Stabilized amorphous calcium carbonate for treatment of neurological, muscular and infertility diseases or conditions |
Non-Patent Citations (5)
Title |
---|
AGRAWAL S.K.: "IN 2015MU03117: A fixed-dose pharmaceutical composition for treatment of thalassemia", IN 2015MU03117, 28 October 2016 (2016-10-28), pages 1 - 20, XP093011676, Retrieved from the Internet <URL:https://content2.cas.org/v1/AUTH_9a355bb5cefd4c378bde0d541c6a11ce/patentpak-cdr-full-text-118/patent/77201124_1537160410.pdf?temp_url_sig=816ca0fa9c111efcdb016bbc70b45eb213e756ad&temp_url_expires=1672875297&inline> * |
BARATI ERFANEH ET AL: "Oxidative stress and male infertility: current knowledge of pathophysiology and role of antioxidant therapy in disease management", CMLS CELLULAR AND MOLECULAR LIFE SCIENCES, BIRKHAUSER VERLAG, HEIDELBERG, DE, vol. 77, no. 1, 3 August 2019 (2019-08-03), pages 93 - 113, XP036986967, ISSN: 1420-682X, [retrieved on 20190803], DOI: 10.1007/S00018-019-03253-8 * |
BEIGI HARCHEGANI ASGHAR ET AL: "Possible mechanisms for the effects of calcium deficiency on male infertility", INTERNATIONAL JOURNAL OF FERTILITY & STERILITY, 1 January 2019 (2019-01-01), Iran, pages 267 - 272, XP093005422, Retrieved from the Internet <URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186280/pdf/Int-J-Fertil-Steril-12-267.pdf> [retrieved on 20221206], DOI: 10.22074/ijfs.2019.5420 * |
DATABASE Biosis [online] 1 January 1991 (1991-01-01), PATNAIK S. M. ET AL: "EFFECT OF CALCIUM SALTS AND RELATED SUBSTANCES ON THE MOTILITY AND VIABILITY EJACULATED HUMAN SPERMATOZOA IN-VITRO", XP093005588, retrieved from https://pubmed.ncbi.nlm.nih.gov/1794893/ Database accession no. PREV199293022888 * |
DATABASE Chemical Abstracts [online] 28 October 2016 (2016-10-28), AGRAWAL S. K.: "A fixed-dose pharmaceutical composition for treatment of thalassemia", XP093011683, retrieved from https://content2.cas.org/v1/AUTH_9a355bb5cefd4c378bde0d541c6a11ce/patentpak-cdr-full-text-118/patent/77201124_1537160410.pdf?temp_url_sig=816ca0fa9c111efcdb016bbc70b45eb213e756ad&temp_url_expires=1672875297&inline Database accession no. 2016:1778604 * |
Also Published As
Publication number | Publication date |
---|---|
WO2023228062A1 (en) | 2023-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2021003036A2 (es) | Compuestos de anillo fusionado | |
CO2021005987A2 (es) | Compuestos de anillo fusionado | |
BR112017012377A2 (pt) | conjugados anticorpo-fármaco com inibidores de bcl-xl permeáveis à célula | |
MX2020004932A (es) | Compuestos utiles para inhibir a cdk7. | |
BRPI0520669A2 (pt) | dosagem farmacêutica que reduz o efeito do alimento encontrado para administração de atorvastatina | |
CO7111284A2 (es) | Nucleósidos de espirooxetano de uracilo | |
GB202019241D0 (en) | Pharmaceutical composition | |
BR112021017350A2 (pt) | Combinação de conjugado de anticorpo-derivado de pirrolobenzodiazepina e inibidor de parp | |
BR112022000337A2 (pt) | Conjugados de peptídeos de citotoxinas como terapêuticos | |
BR112022008365A2 (pt) | Inibidores de cd73 | |
CO2020004669A2 (es) | Derivados de bencimidazol y sus usos | |
ITUA20162575A1 (it) | Composizione farmaceutica o nutraceutica per l’uso nel trattamento della sindrome dell’ovaio policistico o di malattie o disturbi correlati ad essa | |
IT202200010583A1 (it) | “Composizione nutraceutica o farmaceutica per l’infertilità maschile” | |
IT202200010592A1 (it) | “Composizione nutraceutica o farmaceutica per l’infertilità maschile” | |
IT202200010280A1 (it) | “Composizione nutraceutica o farmaceutica per l’infertilità maschile” | |
IT202200010277A1 (it) | “Composizione nutraceutica o farmaceutica per l’infertilità maschile” | |
IT202200010274A1 (it) | “Composizione nutraceutica o farmaceutica per l’infertilità maschile” | |
DK4153133T3 (da) | Injicerbare farmaceutiske sammensætninger og anvendelser deraf | |
IT202200004958A1 (it) | “Composizione nutraceutica o farmaceutica per il benessere renale” | |
IT202200008867A1 (it) | “Composizione nutraceutica o farmaceutica per la salute cardiovascolare” | |
IT202200008879A1 (it) | “Composizione nutraceutica o farmaceutica per la salute cardiovascolare” | |
IT202200008534A1 (it) | “Composizione nutraceutica o farmaceutica per la salute cardiovascolare” | |
IT202200008537A1 (it) | “Composizione nutraceutica o farmaceutica per la salute cardiovascolare” | |
CR20220587A (es) | Formulaciones farmacéuticas | |
CO2024005025A2 (es) | Composiciones líquidas orales de enzalutamida |